Gradient Toxicologist Lindsey Borton Receives Society of Toxicology Award
Gradient Toxicologist
Read the published paper in ALTEX: Borton, L; Coleman, K. 2025. "Material-mediated pyrogens in medical devices: Myth or reality?" ALTEX – Altern. Anim. Ex. doi: 10.14573/altex.2504231.
See more detail about this paper on Gradient's website.
According to the Society of Toxicology Medical Device and Combination Product Specialty Section website," The SOT Specialty Sections represent the breadth and diversity of the toxicological sciences by focusing on specific toxicological areas." The Medical Device and Combination Product Specialty Section has a purpose of "providing an international forum where government, industry, and academic toxicologists can share state-of-the-art knowledge and develop new approaches for the evaluation of medical devices."
One paper is selected to receive the Best Published Paper Award, Medical Device and Combination Product Specialty Section each year.
Ms.
Please join us in congratulating
Gradient is an environmental and risk sciences consulting firm renowned for scientific excellence. We provide cutting-edge risk sciences consulting services to design and strategize responsive and protective solutions to environmental and human health challenges.
Contact:
Director of Marketing, Gradient
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/gradient-toxicologist-lindsey-borton-receives-society-of-toxicology-award-302727388.html
SOURCE Gradient LLC
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Best Affordable Luxury Sunglasses (2026): Designer Look Quay Frames Featured Among Stylish Options Without the High Price Tag by Expert Consumers
- Marketing Maven CEO and Founder, Lindsey Carnett, to Keynote Elevate's Inspiring Women in Business Event
- WorldSkills Shanghai 2026 Opens with 1,385 Competitors from 68 Countries and Regions
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share